Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Emery

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drugs in R&D|August 30, 2008
Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteersDesmond Padhi, Maggi Salfi, Maurice Emery
Expert Review of Cardiovascular Therapy|April 1, 2015
Evolocumab (AMG 145) for primary hypercholesterolemiaGisle Langslet, Maurice Emery, Scott M Wasserman
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Discovery of novel nonsteroidal glucocorticoid receptor modulatorsJ T Link, Bryan K Sorensen, Jyoti Patel, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Bile acid conjugates of a nonsteroidal glucocorticoid receptor modulatorNoah Tu, J T Link, Bryan K Sorensen, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonistBryan K Sorensen, J T Link, Thomas von Geldern, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulatorsJ T Link, Bryan K Sorensen, Jyoti Patel, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybridsJ T Link, Bryan K Sorensen, Chunqiu Lai, et al.
Journal of Pharmaceutical Sciences|February 3, 2015
Utilizing physiologically based pharmacokinetic modeling to inform formulation and clinical development for a compound with pH-dependent solubilityJohn Chung, Fernando Alvarez-Nunez, Vincent Chow, et al.
Journal of Medicinal Chemistry|April 19, 2008
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 miceLars Johansson, Christopher Fotsch, Michael D Bartberger, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2007
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitorsChester Yuan, David J St Jean, Qingyian Liu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drugs in R&D|August 30, 2008
Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteersDesmond Padhi, Maggi Salfi, Maurice Emery
Expert Review of Cardiovascular Therapy|April 1, 2015
Evolocumab (AMG 145) for primary hypercholesterolemiaGisle Langslet, Maurice Emery, Scott M Wasserman
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Discovery of novel nonsteroidal glucocorticoid receptor modulatorsJ T Link, Bryan K Sorensen, Jyoti Patel, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Bile acid conjugates of a nonsteroidal glucocorticoid receptor modulatorNoah Tu, J T Link, Bryan K Sorensen, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonistBryan K Sorensen, J T Link, Thomas von Geldern, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulatorsJ T Link, Bryan K Sorensen, Jyoti Patel, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybridsJ T Link, Bryan K Sorensen, Chunqiu Lai, et al.
Journal of Pharmaceutical Sciences|February 3, 2015
Utilizing physiologically based pharmacokinetic modeling to inform formulation and clinical development for a compound with pH-dependent solubilityJohn Chung, Fernando Alvarez-Nunez, Vincent Chow, et al.
Journal of Medicinal Chemistry|April 19, 2008
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 miceLars Johansson, Christopher Fotsch, Michael D Bartberger, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2007
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitorsChester Yuan, David J St Jean, Qingyian Liu, et al.
Pageof 2